| Code | Description | Claims | Beneficiaries | Total Paid |
| T1015 |
Clinic visit/encounter, all-inclusive |
27,963 |
22,036 |
$1.33M |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
3,024 |
2,319 |
$48K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
4,577 |
3,515 |
$26K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
4,285 |
3,322 |
$20K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
18,638 |
15,392 |
$9K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
715 |
638 |
$5K |
| 99215 |
Prolong outpt/office vis |
8,041 |
6,847 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,011 |
925 |
$490.21 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
186 |
182 |
$284.45 |
| 87428 |
|
260 |
198 |
$100.00 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
446 |
434 |
$82.12 |
| 81002 |
|
1,078 |
1,061 |
$40.94 |
| 0013A |
|
21 |
21 |
$40.00 |
| 85013 |
|
990 |
976 |
$39.20 |
| 99072 |
|
1,051 |
921 |
$29.10 |
| 90688 |
|
546 |
541 |
$25.34 |
| 99173 |
|
863 |
858 |
$9.81 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
261 |
258 |
$8.16 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,031 |
993 |
$6.99 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,840 |
1,712 |
$4.46 |
| 3078F |
|
1,497 |
1,317 |
$0.00 |
| 90734 |
|
13 |
13 |
$0.00 |
| 3077F |
|
884 |
791 |
$0.00 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
203 |
200 |
$0.00 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
162 |
159 |
$0.00 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
30 |
29 |
$0.00 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
12 |
12 |
$0.00 |
| 91300 |
|
122 |
106 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
52 |
38 |
$0.00 |
| 90715 |
|
29 |
29 |
$0.00 |
| 90658 |
|
14 |
14 |
$0.00 |
| 81025 |
|
13 |
12 |
$0.00 |
| 92551 |
|
876 |
871 |
$0.00 |
| 90686 |
|
437 |
432 |
$0.00 |
| 3074F |
|
1,332 |
1,166 |
$0.00 |
| 3079F |
|
898 |
828 |
$0.00 |
| 3080F |
|
484 |
446 |
$0.00 |
| 85018 |
|
486 |
474 |
$0.00 |
| 3075F |
|
644 |
594 |
$0.00 |
| 91307 |
|
21 |
21 |
$0.00 |
| 91301 |
|
274 |
262 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
65 |
59 |
$0.00 |
| 90651 |
|
55 |
55 |
$0.00 |
| 88142 |
|
38 |
38 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
15 |
14 |
$0.00 |
| 86580 |
|
25 |
24 |
$0.00 |
| 96127 |
|
12 |
12 |
$0.00 |
| 0011A |
|
17 |
17 |
$0.00 |
| 0012A |
|
17 |
17 |
$0.00 |
| 90619 |
|
12 |
12 |
$0.00 |